Recent Patents on Anti-Cancer Drug Discovery
Volume 15, 4 Issues, 2020
ISSN: 2212-3970 (Online)
ISSN: 1574-8928 (Print)
This journal supports open access
ISSN: 2212-3970 (Online)
ISSN: 1574-8928 (Print)
This journal supports open access
  |
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Contents
Recent Patents on Anti-Cancer Drug Discovery, Volume 13 - Number 1
Biography Open Access
Review Article Open Access
Nucleic Acid Sensing Machinery: Targeting Innate Immune System for Cancer Therapy
, 13(1): 2 - 17Sandra Iurescia*, Daniela Fioretti and Monica Rinaldi*
DOI: 10.2174/1574892812666171030163804
Review Article Open Access
Strategies to Tackle Radiation Resistance by Penetrating Cancer Stem Cell Line of Scrimmage
, 13(1): 18 - 39So-Yeon Park, Ji-Young Kim, Youngsoo Jun and Jeong-Seok Nam*
DOI: 10.2174/1574892812666171003150410
Review Article
Adenosine Receptor Ligands on Cancer Therapy: A Review of Patent Literature
, 13(1): 40 - 69Joana B. Sousa, Paula Fresco, Carmen Diniz* and Jorge Goncalves
DOI: 10.2174/1574892812666171108115959
Review Article
Brain Cancer: Implication to Disease, Therapeutic Strategies and Tumor Targeted Drug Delivery Approaches
, 13(1): 70 - 85Viral Shah* and Pratiksha Kochar
DOI: 10.2174/1574892812666171129142023
Review Article Open Access
Use of human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors in Autoimmune Diseases and New Perspectives in Cancer Therapy
, 13(1): 86 - 105Marco L. Lolli, Stefano Sainas, Agnese C. Pippione, Marta Giorgis, Donatella Boschi and Franco Dosio*
DOI: 10.2174/1574892812666171108124218
Review Article
NLRP3 Inflammasome Activation Inhibitors in Inflammation-Associated Cancer Immunotherapy: An Update on the Recent Patents
, 13(1): 106 - 117Spandana R. Kopalli , Tae-Bong Kang , Kwang-Ho Lee and Sushruta Koppula*
DOI: 10.2174/1574892812666171027102627
Research Article
The Epithelial-Mesenchymal Transition Pathway in Two Cases with Gastric Metastasis Originating from Breast Carcinoma, One with a Metachronous Primary Gastric Cancer
, 13(1): 118 - 124Simona Gurzu*, Laura Banias*, Tivadar Bara, Feher I, Tivadar Jr. Bara and Ioan Jung
DOI: 10.2174/2212798409666171101121108
Patent Selections Open Access
Editor-in-Chief
Zhe-Sheng (Jason) Chen
Institute for Biotechnology
College of Pharmacy and Health Sciences
St. John's University
New York, NY
(USA)
Biography
Institute for Biotechnology
College of Pharmacy and Health Sciences
St. John's University
New York, NY
Biography
Biography of Zhe-Sheng (Jason) Chen
Dr. Chen obtained a doctorate (Ph.D.) in Pharmacology from the Kagoshima University, Japan. He also holds an MD degree from Guangdong Medical and Pharmaceutical College and a Master's degree in Toxicology from Sun Yat-Sen University, China. Currently, Dr. Chen is a Professor at St. John’s University College of Pharmacy and Health Sciences. He is also a director of the Institute for Biotechnology at St. John’s University. He has published more than 270 scientific publications. Besides, he is the founding Editor in Chief of the Journal of Cancer Research Updates, an Editor-in-Chief of the Journal of New Developments in Chemistry and an editor of the African Journal of Pharmacy and Pharmacology. He is also an editorial board member of 26 journals and a reviewer of more than 240 peer-reviewed journals.
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Recent Patents on Anti-Cancer Drug Discovery was launched in 2006. Prof. Zhe-Sheng (Jason) Chen serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.52
Advertisement
Webmaster Contact: info@benthamscience.net